GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study
- Resource Type
- ACADEMIC JOURNAL
- Authors
- Mendoza-Tesarik, Raquel a; Mendoza, Nicolas a, b; López, Cristina Conde a, c; Tesarik, Jan a, ⁎
- Source
- In Reproductive BioMedicine Online August 2019 39(2):225-230
- Subject
- Language
- English
- ISSN
- 1472-6483
- E-ISSN
- DOI
- 10.1016/j.rbmo.2019.03.215
Conclusions In patients with luteal phase deficiency, the administration of GnRH agonist after embryo transfer increases serum progesterone concentration and improves the chance of pregnancy and birth.